Cargando…
Albumin administration in the acutely ill: what is new and where next?
Albumin solutions have been used worldwide for the treatment of critically ill patients since they became commercially available in the 1940s. However, their use has become the subject of criticism and debate in more recent years. Importantly, all fluid solutions have potential benefits and drawback...
Autores principales: | Vincent, Jean-Louis, Russell, James A, Jacob, Matthias, Martin, Greg, Guidet, Bertrand, Wernerman, Jan, Roca, Ricard Ferrer, McCluskey, Stuart A, Gattinoni, Luciano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223404/ https://www.ncbi.nlm.nih.gov/pubmed/25042164 http://dx.doi.org/10.1186/cc13991 |
Ejemplares similares
-
Erratum to: Albumin administration in the acutely ill: what is new and where next?
por: Vincent, Jean-Louis, et al.
Publicado: (2014) -
Growth hormone does not affect albumin synthesis in the critically ill
por: Barle, Hans, et al.
Publicado: (2001) -
Biochemical shunt: where and how?
por: Busana, Mattia, et al.
Publicado: (2022) -
Albumin mass balance and kinetics in liver transplantation
por: Amouzandeh, Mariam, et al.
Publicado: (2018) -
Specific antioxidant properties of human serum albumin
por: Taverna, Myriam, et al.
Publicado: (2013)